Find Academic Supervisors

Francesca StradoliniView profile

Lecturer

• Bioelectronics
• IoT for Medical Monitoring
• Anesthesia Delivery Systems
• +3 more

Francesca Stradolini is a Lecturer at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the Electrical Engineering Doctoral School (EDEE). She holds a PhD in Electrical Engineering from EPFL (2018), with prior education in Bio Engineering and Neuroscience from the University of Genoa (2012, 2015). Her current work focuses on R&D engineering for medical devices, emphasizing system lifecycle management, human factors engineering, and compliance with CE/FDA regulations. As an invited guest, she contributes to usability engineering education and interdisciplinary research at EPFL. PhD: IoT Bio-Electronic Multi-Panel Device for On-line Monitoring of Anaesthesia Delivery (EPFL, 2018) MSc: Bio Engineering (University of Genoa, 2015) BSc: Bio Engineering (University of Genoa, 2012) Her research spans bioelectronics, IoT-enabled medical monitoring, and electrochemical sensor development for clinical applications. Key areas include anesthesia delivery systems, wearable diagnostics, implantable devices, and human factors engineering. Her work integrates fluidic systems, noble metal nanostructures, and open-source hardware (e.g., Raspberry Pi) to address challenges in traceability, fouling mitigation, and pharmacokinetic modeling. Scientific recognition includes the Ville de Lausanne Award (2019) , EPFL Outstanding PhD Thesis Distinction (2018) , and a Best Paper Award at MOBIHEALTH (2016) . She has published extensively in journals like IEEE TBIOCAS, Sensors and Actuators B, and IEEE Sensors Journal, with collaborative studies on propofol monitoring, carbon nanoallotrope drug detection, and implantable sensor validation. Her technical expertise includes managing medical device development lifecycles, designing IoT architectures for intensive care, and optimizing electrochemical sensors for stability in undiluted biological fluids. She has contributed to conferences such as IEEE BioCAS, ISCAS, and MOBIHEALTH, focusing on translational studies in personalized medicine and 3D-printed medical systems.

Weiqiang ChenView profile

Professor

• Lab-on-a-Chip
• Organ-on-Chip
• Biomaterials
• +7 more

Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.

Urs JenalView profile

Professor

• Bacterial Signal Transduction
• Microbiology
• Antibiotic Resistance
• +5 more

Professor Urs Jenal is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he has led research on bacterial signal transduction since 2008. His laboratory investigates the molecular mechanisms of bacterial persistence and antibiotic resistance, with particular focus on pathogens causing chronic infections in humans. Previously, he served as Associate Professor (2002-2008) and Assistant Professor (1996-2002) at the same institution, and completed postdoctoral training at Stanford University and ETH Zurich. Education 2000: Habilitation and VENIA DOCENDI in Microbiology, University of Basel 1987-1991: PhD in Molecular Microbiology, ETH Zurich (supervisor: Prof. T. Leisinger) 1982-1986: Studies of Experimental Biology, ETH Zurich 1977-1981: Gymnasium with Matura Type C, Chur Research Focus Prof. Jenal's research centers on understanding how bacterial pathogens persist in the human body despite antibiotic treatments. His laboratory investigates cyclic nucleotides, particularly c-di-GMP, as signaling molecules that control bacterial biofilm formation, virulence, and antibiotic tolerance. His team studies pathogenic Escherichia coli causing recurrent urinary tract infections and Pseudomonas aeruginosa causing long-term lung infections in cystic fibrosis patients. Recent work has revealed how "sleeping" bacteria survive antibiotic treatments and how pathogens breach respiratory epithelia through goblet cell invasion. Scientific Recognition 2014: Elected member of the European Academy of Microbiology (EAM) 2013: ERC Advanced Investigator Award 2012: Elected member of the European Molecular Biology Organization (EMBO) 2011: Elected member of the American Academy of Microbiology (AAM) Mentorship and Collaborations Prof. Jenal has mentored numerous PhD students and postdocs, many receiving awards for their research. His laboratory is part of the NCCR AntiResist initiative focused on developing novel approaches against antibiotic resistance. He collaborates extensively with clinical researchers and has developed innovative models, including human mini-lungs, to investigate pathogen-host interactions. His recent publications demonstrate how understanding bacterial persistence mechanisms can lead to new therapeutic strategies against chronic infections.

Thomas WinklerView profile

Associate Professor

• Microsystems Technology
• Organ-on-Chip
• Neuropsychiatric Disorders
• +3 more

Thomas Winkler is an Associate Professor at the Division of Micro and Nanosystems, KTH Royal Institute of Technology, Sweden, and collaborates with TU Braunschweig, Germany. His research focuses on solving life science challenges using microsystems tools, particularly in neuropsychiatric disorders like schizophrenia. He develops organ-on-chip models, engineered microfluidic platforms, and biosensors for point-of-care diagnostics. Winkler leads an interdisciplinary ERC-funded team addressing metabolic coupling in neurovascular units and oxidative stress biomarkers. Key achievements include the ERC Starting Grant (2023) and work on electrochemical sensors for clozapine monitoring. He teaches courses such as Microsystem Technology (EK2350) and supervises PhD and postdoctoral researchers. Current projects include machine learning-guided robotic organoid maturation and electrochemical technology development for the CHIPzophrenia initiative. His lab actively seeks talent through open positions in Stockholm and Braunschweig. Scientific awards include the ERC Starting Grant and Marie Skłodowska-Curie Actions Fellowship. Research spans sensor development, microfabrication, and biomaterials, with a focus on translating lab technologies to clinical applications. Collaborations bridge engineering and life sciences, emphasizing personalized mental healthcare solutions.

Su Ryon ShinView profile

Assistant Professor

• Bioengineering
• Tissue Engineering
• 3D Bioprinting
• +7 more

Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.

Kevin HealyView profile

Professor

• Biomaterials
• Nanotechnology
• Cell and Tissue Engineering
• +3 more

Kevin Healy is a Professor in Bioengineering and Materials Science & Engineering at the University of California, Berkeley. His research focuses on the interaction between biomaterials and cellular/tissue systems, with an emphasis on designing bioinspired materials that control cell fate and enable tissue regeneration. The Healy Lab investigates tunable material properties (biological content and mechanical cues) to direct cellular behavior and develop novel therapeutic approaches. His expertise spans Human stem cell technologies Microphysiological systems Drug delivery systems Bioconjugate therapeutics Professor Healy's work has major implications for regenerative medicine and tissue engineering through material science innovations.

James McGrathView profile

Professor

• Nanomembranes
• Microphysiological systems
• Biosensors
• +7 more

James McGrath is a Professor of Biomedical Engineering at the University of Rochester, holding the William R. Kenan, Jr. Professorship. He leads the Nanomembrane Research Group, pioneering ultrathin silicon nanomembrane technologies for biomedical applications. His work integrates material science, microfluidics, and tissue engineering to address challenges in diagnostics, regenerative medicine, and environmental health. McGrath's interdisciplinary team collaborates across academia and industry, including the Rochester-based SiMPore Inc. (co-founded by him). Education: B.S. Mechanical Engineering, Arizona State University (1991) M.S. Mechanical Engineering, MIT (1994) Ph.D. Biological Engineering, Harvard/MIT (1998) Research Interests: McGrath focuses on nanomembrane technologies for: Microphysiological systems (organ-on-a-chip) Biosensors and diagnostic tools Hemodialysis and toxin removal Microplastics detection in water and biological systems Inflammatory fibrosis modeling (e.g., blood-brain barrier dynamics) Extracellular vesicle biomarker platforms Awards & Recognition: Edmund A. Hajim Outstanding Faculty Award (2019) AIMBE Fellow (2015) William R. Kenan, Jr. Professorship (2023) Advising & Industry: McGrath has advised students and entrepreneurs through his lab and SiMPore Inc., focusing on translating nanomembrane innovations into clinical and commercial applications. His work bridges basic science and applied engineering, with a focus on scalable manufacturing and global health impact. Labs & Collaborations: The Nanomembrane Research Group collaborates with UR, RIT, and international partners to advance nanomembrane-based solutions for healthcare and environmental challenges. Key platforms include the MicroSiM barrier tissue system and silicon nanomembrane analysis pipelines.

Johan Ulrik LindView profile

Associate Professor

• Additive Manufacturing
• Tissue Engineering
• Functional Materials
• +6 more

Johan Ulrik Lind is an Associate Professor and Groupleader at the Department of Health Technology, Technical University of Denmark. His research focuses on cutting-edge biomedical engineering solutions including tissue engineering, bioprinting, and microphysiological systems. He actively contributes to additive manufacturing and functional materials development. Current Affiliation: Department of Health Technology, DTU Research Areas: 3D bioprinting, hydrogel technologies, microsystems engineering Expertise: UN Sustainable Development Goals for health and well-being Lind's work spans additive manufacturing for tissue engineering, functionalized biomaterials , and dynamic microphysiological systems . His recent publications highlight innovations in hydrogel formulation, bioink development, and particulate drug delivery systems. Notably, he holds a patent for transparent bioink formulation. He supervises multiple PhD projects including: micro-perfused bioartificial ovaries, embedded bioprinting of perfusable vasculatures, and 3D printed microsystems for tissue actuation. His research portfolio demonstrates strong interdisciplinary collaboration across engineering, biology, and pharmaceutical sciences.

Megan Laura McCainView profile

Professor

• Biomedical Engineering
• Tissue Engineering
• Regenerative Medicine
• +4 more

Megan Laura McCain is a Professor of Biomedical Engineering at the University of Southern California (USC), with a secondary appointment in the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine. She leads the McCain Lab, focused on developing microphysiological systems, particularly heart- and muscle-on-a-chip models, to study disease mechanisms and therapeutic responses. McCain holds affiliations with the Biomedical Engineering Society, American Society for Cell Biology, and American Heart Association. Her education includes a B.S. in Biomedical Engineering from Washington University in St. Louis (2006), a Ph.D. in Engineering and Applied Sciences from Harvard University (2012), and postdoctoral research at Harvard’s Wyss Institute. Notable awards include the American Heart Association Pre-doctoral Fellowship and Harvard’s Derek Bok Certificate of Distinction in Teaching. McCain’s research integrates tissue engineering, stem cell biology, and microfluidics to model complex biological systems. Her work emphasizes understanding how microenvironments influence cellular behavior in diseases like cardiovascular disorders and muscular dystrophy. Recent studies explore paracrine interactions in engineered tissues, sex-based proteomic differences in vascular cells, and hypoxia-induced signaling in cardiac fibroblasts. Her scientific contributions include advancements in 3D bioprinting, microfluidic platforms for disease modeling, and synthetic biology tools for cellular control. McCain’s lab collaborates widely to translate findings into clinical applications, such as personalized medicine and regenerative therapies.

• Biomaterials
• Regenerative Medicine
• Tissue Engineering
• +4 more

Prof. Elisabeth Engel López leads the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) and serves as a Professor at the Technical University of Catalonia. With over 80 publications in JCR journals, her work focuses on designing biomaterials and scaffolds for in vitro/in vivo regenerative medicine, emphasizing cellular response mechanisms and translational applications. Developing lactate-releasing systems for metabolic modulation Advancing 3D bioprinting for tissue-specific models Engineering angiogenic and osteogenic biomaterials Her research bridges fundamental studies with industrial partnerships, including pharmaceutical and biomedical device companies, and contributes to European collaborative projects. She received the Barcelona City Award for technological research and has delivered numerous invited lectures. Her group explores substrate stiffness, ion release, and microenvironmental cues to control cell behavior in cardiac, neural, and bone regeneration contexts.

Michael GrabeView profile

Professor

• Ion Channel Function
• Membrane Biology
• Computational Biology
• +3 more

Michael Grabe is a Professor in the Cardiovascular Research Institute (CVRI) at the University of California San Francisco (UCSF). He holds a joint appointment in the Department of Pharmaceutical Chemistry. His work focuses on computational methods to study biological phenomena, particularly ion transport across membranes and the molecular mechanisms of ion channels/transporters. He has pioneered theoretical approaches to understand membrane protein function and organelle acidity regulation. Education: PhD in Physics, University of California, Berkeley (2002) ScB in Mathematics-Physics, Brown University (1996) Research Interests: Dr. Grabe’s lab investigates ion channel function, membrane remodeling by TMEM16 proteins, lysosomal pH regulation, and computational modeling of membrane-associated processes. Key themes include: Mechanics of ion transport and lipid flipping Protein-induced membrane deformations Simulations of organelle microphysiology Development of computational tools for membrane protein analysis Recent Research Trends: Recent work emphasizes dynamic protein design using AI (e.g., Science 2025), structural studies of K2P channels, and functional insights into TMEM16 scramblases. His team also explores SARS-CoV-2 protein interactions and mitochondrial uncoupling mechanisms. Awards: NSF CAREER Award (2009-2014) Alfred P. Sloan Research Fellowship (2009-2011) Shining Star Community Service Award (2012) Grants & Advising: Principal Investigator of NIH grants studying TMEM16 proteins (R01GM137109) and lysosomal physiology (R21GM100224). His lab trains graduate students and postdocs in computational biophysics and membrane biology. Labs/Teams: Leads the Grabe Lab at UCSF, which collaborates with experimental groups to bridge theory and experiment in membrane systems. Active in developing open-source tools like APBSmem for electrostatic calculations.

Deok-Ho KimView profile

Professor

• Stem cell engineering
• Tissue engineering
• Organs-on-chips
• +7 more

Deok-Ho Kim, PhD, is a Professor in the Department of Biomedical Engineering at Johns Hopkins University. His research focuses on integrating nanotechnology, biomaterials, and mechanobiology to advance tissue engineering, regenerative medicine, and disease modeling. Key areas include stem cell engineering, organs-on-chips, and bio-inspired materials for drug screening and cell-based therapies. Education: PhD in Biomedical Engineering from Johns Hopkins University (2010), MS in Mechanical Engineering from Seoul National University (2000), and BS in Mechanical Engineering from POSTECH (1998). Research emphasizes understanding how mechanical and biochemical signals regulate cell behavior in health and disease. Notable work includes microphysiological systems (MPS) for precision medicine, spaceflight effects on cardiac function, and engineered heart tissue models. Recent studies highlighted the impact of microgravity on heart cells and the role of LOXL2 in hypertension. Laboratory: Kim Lab develops cutting-edge tools like nanopatterned electrodes and biomimetic substrates. Collaborations span academia and industry, with media features in Scientific American and coverage of heart-on-a-chip studies in space. Grants and Funding: Active in securing federal and foundation grants for tissue engineering and biomaterials research. Advising: No formal student list provided, but mentors trainees in multidisciplinary approaches.

Shang SongView profile

Assistant Professor

• Biomaterials
• Stem Cell Therapy
• Regenerative Medicine
• +4 more

Shang Song is an Assistant Professor of Biomedical Engineering and Materials Science and Engineering at the University of Arizona , where she leads the Integrated BioDesign Lab. Her work bridges advanced engineering methods with cell therapies to develop microphysiological platforms and regenerative treatments. Education: PhD in Bioengineering from University of California Berkeley and University of California San Francisco BS in Biomedical Engineering (Honors) from Brown University Dr. Song's research focuses on manipulating cellular microenvironments to create novel therapeutics. Key areas include conductive biomaterials for stem cell therapy, organ-on-chip systems , and neural repair through electrical stimulation. Her work spans molecular, cellular, and organ-level biological scales to address translational challenges in human health. Recent publications highlight trends in conductive hydrogels , electrical modulation of stem cells , and microfluidic blood-brain barrier modeling . These align with her lab's emphasis on multi-scale engineering solutions for regenerative medicine. Scientific Awards: George H. Davis Fellowship (2025) ORAU Ralph E. Powe Junior Faculty Enhancement Award (2024) American Heart Association Career Development Award (2024) Arizona Biomedical Research Centre New Investigator Award (2024) NIH F32 Fellowship (2019) Forbes 30 Under 30 (2016) NSF Graduate Research Fellowship (2010) Gates Millennium Scholar (2006) Her lab integrates advanced engineering design with disease-mimicking models to create organs-on-chips platforms and regenerative strategies that address clinical needs through cross-disciplinary innovation.

Gerald UrbanView profile

Professor

• Biomedical Microtechnology
• Sensorics
• Microsystem Technology
• +7 more

Prof. Dr. Gerald Urban is a distinguished Professor at the Institute for Microsystems Technology (IMTEK) within the Faculty of Engineering at the University of Freiburg, Germany. With over three decades of academic and research experience, he has established himself as a leading expert in biomedical microtechnology and sensor systems. His career spans prestigious institutions including the Vienna University of Technology and collaborations with major research centers worldwide. His educational journey includes: 1973: Graduated from Sigmund Freud Gymnasium in Vienna 1979: Completed studies in Technical Physics at Vienna University of Technology 1985: Earned Doctorate (Dr.-Ing.) with distinction (Summa cum Laude) from Vienna University of Technology 1994: Completed habilitation in Sensorics Prof. Urban's research focuses on the development and application of miniaturized integrated sensors for clinical and industrial applications. His work bridges the gap between fundamental materials science and practical medical devices, with particular emphasis on biomedical microtechnology , electrochemical biosensors , and organ-on-chip systems . His team has pioneered innovations in point-of-care diagnostics, therapeutic drug monitoring, and micro energy harvesting technologies. The research group maintains strong collaborations with clinical partners to ensure translational impact of their technological developments. Analysis of Prof. Urban's recent publications reveals a clear trajectory toward increasingly sophisticated multiplexed sensing platforms that integrate CRISPR-based diagnostics with electrochemical detection systems. His work demonstrates growing emphasis on point-of-care applications, with particular focus on making complex diagnostic capabilities accessible outside traditional laboratory settings. The integration of additive manufacturing techniques with sensor technology represents another significant trend in his recent work, enabling customized microreactor and organ-on-chip platforms. Among his notable scientific achievements: Stefan Schuy Prize for Biomedical Engineering (1990) AVL-List Prize (1993) Best Poster at Eurosensors (1993) Hoechst-Price (1994) Corresponding member of the Austrian Academy of Sciences (2010) EAMBES-Fellow (2018) Prof. Urban has successfully secured substantial research funding throughout his career, with accumulated third-party funding reaching approximately 5 million euros between 1986-1995. He has established multiple spin-off companies including Otto Sensorenfabrikationsgesellschaft (1985), Biosensor GnbR (1994), and Jobst Technologies GmbH (2002), demonstrating his commitment to translating research into practical applications. His leadership extends to major research initiatives including the excellence initiative "µMAT" and the graduate school "PolyMIC". At the University of Freiburg, Prof. Urban leads a vibrant research group within the Institute for Microsystems Technology, which forms part of the larger BrainLinks-BrainTools and BIOSS research clusters. His laboratory maintains state-of-the-art facilities for microsensor fabrication, including cleanroom access through the WebFab service center. The research environment benefits from strong connections with the Freiburg Material Research Center (FMF) and the Freiburg Institute for Advanced Studies (FRIAS), where he served as an Internal Fellow (2008-2010).

Sara Pedron HabaView profile

Academic

• Biomaterials for Tissue Engineering
• Bioactive Microenvironments
• Brain Cancer Research
• +4 more

Sara Pedron Haba is a Research Assistant Professor at the University of Illinois at Urbana-Champaign, affiliated with the Carle Illinois College of Medicine, Carl R. Woese Institute for Genomic Biology, and Department of Chemical & Biomolecular Engineering. She holds a PhD in Materials Science and Engineering from the University Carlos III Madrid and a BS in Chemistry from the University of Valencia. Her research focuses on developing biomaterial-based platforms to study brain physiology and neurological diseases, particularly glioblastoma. Key research areas include biomaterials for tissue engineering, tumor microenvironment modeling, and hyaluronic acid's role in cancer progression. Dr. Haba's work emphasizes creating microphysiological systems to bridge the gap between in vitro models and clinical applications. She has received notable awards, including the AACR NextGen Star (2021) and the Nature Publishing Award from the Society for Biomaterials (2016). Her lab collaborates widely, integrating expertise from chemical engineering, biomedical science, and oncology to advance therapeutic strategies for brain cancers. Education: PhD, Materials Science and Engineering, University Carlos III Madrid (2004–2009) BS, Chemistry, University of Valencia (2001) Awards: NextGen Star, AACR (2021) Nature Publishing Award, Society for Biomaterials (2016) CPLC 10K Pilot Program (2014) Research Themes: Biomaterials for brain tumor modeling Extracellular matrix dynamics in glioblastoma Therapeutic efficacy assessment platforms Her lab's efforts aim to improve patient-specific therapies and understand tumor-stroma interactions through innovative biomaterial systems.